Increased colonic expression of ACE2 associates with poor prognosis in Crohn’s disease
Public Deposited
Add to collection
You do not have access to any existing collections. You may create a new collection.
Citation
MLA
Toyonaga, Takahiko, et al. Increased Colonic Expression of Ace2 Associates with Poor Prognosis In Crohn’s Disease. 2021. https://doi.org/10.17615/4zbm-yn86APA
Toyonaga, T., Araba, K., Kennedy, M., Keith, B., Wolber, E., Beasley, C., Steinbach, E., Schaner, M., Jain, A., Long, M., Barnes, E., Herfarth, H., Isaacs, K., Hansen, J., Kapadia, M., Guillem, J., Gulati, A., Sethupathy, P., Furey, T., Ehre, C., & Sheikh, S. (2021). Increased colonic expression of ACE2 associates with poor prognosis in Crohn’s disease. https://doi.org/10.17615/4zbm-yn86Chicago
Toyonaga, Takahiko, Kenza C Araba, Meaghan M Kennedy, Benjamin P Keith, Elisabeth A Wolber, Caroline Beasley, Erin C Steinbach et al. 2021. Increased Colonic Expression of Ace2 Associates with Poor Prognosis In Crohn’s Disease. https://doi.org/10.17615/4zbm-yn86- Creator
-
Toyonaga, Takahiko
- Affiliation: Center for Gastrointestinal Biology and Disease
-
Araba, Kenza C.
- Affiliation: School of Medicine, Department of Genetics
-
Kennedy, Meaghan M.
- Affiliation: Center for Gastrointestinal Biology and Disease
-
Keith, Benjamin P.
- Affiliation: Center for Gastrointestinal Biology and Disease
-
Wolber, Elisabeth A.
- Affiliation: Center for Gastrointestinal Biology and Disease
-
Beasley, Caroline
- Affiliation: Center for Gastrointestinal Biology and Disease
-
Steinbach, Erin C.
- Affiliation: Center for Gastrointestinal Biology and Disease
-
Schaner, Matthew R.
- Affiliation: Center for Gastrointestinal Biology and Disease
-
Jain, Animesh
- Affiliation: Center for Gastrointestinal Biology and Disease
-
Long, Millie D.
- Affiliation: Center for Gastrointestinal Biology and Disease
-
Barnes, Edward L.
- Affiliation: Center for Gastrointestinal Biology and Disease
-
Herfarth, Hans H.
- Affiliation: Center for Gastrointestinal Biology and Disease
-
Isaacs, Kim L.
- Affiliation: Center for Gastrointestinal Biology and Disease
-
Hansen, Jonathan J.
- Affiliation: Center for Gastrointestinal Biology and Disease
-
Kapadia, Muneera R.
- Affiliation: School of Medicine, Department of Surgery
-
Guillem, José Gaston
- Affiliation: School of Medicine, Department of Surgery
-
Gulati, Ajay S.
- Affiliation: Center for Gastrointestinal Biology and Disease
-
Sethupathy, Praveen
- Other Affiliation: Cornell University
-
Furey, Terrence S.
- Affiliation: Center for Gastrointestinal Biology and Disease
-
Ehre, Camille
- Affiliation: School of Medicine, Marsico Lung Institute/UNC Cystic Fibrosis Center
-
Sheikh, Shehzad Z.
- Affiliation: Center for Gastrointestinal Biology and Disease
- Abstract
- The host receptor for SARS-CoV-2, angiotensin-converting enzyme 2 (ACE2), is highly expressed in small intestine. Our aim was to study colonic ACE2 expression in Crohn's disease (CD) and non-inflammatory bowel disease (non-IBD) controls. We hypothesized that the colonic expression levels of ACE2 impacts CD course. We examined the expression of colonic ACE2 in 67 adult CD and 14 NIBD control patients using RNA-seq and quantitative (q) RT-PCR. We validated ACE2 protein expression and localization in formalin-fixed, paraffin-embedded matched colon and ileal tissues using immunohistochemistry. The impact of increased ACE2 expression in CD for the risk of surgery was evaluated by a multivariate regression analysis and a Kaplan–Meier estimator. To provide critical support for the generality of our findings, we analyzed previously published RNA-seq data from two large independent cohorts of CD patients. Colonic ACE2 expression was significantly higher in a subset of adult CD patients which was defined as the ACE2-high CD subset. IHC in a sampling of ACE2-high CD patients confirmed high ACE2 protein expression in the colon and ileum compared to ACE2-low CD and NIBD patients. Notably, we found that ACE2-high CD patients are significantly more likely to undergo surgery within 5 years of CD diagnosis, and a Cox regression analysis found that high ACE2 levels is an independent risk factor for surgery (OR 2.17; 95% CI, 1.10–4.26; p = 0.025). Increased intestinal expression of ACE2 is associated with deteriorated clinical outcomes in CD patients. These data point to the need for molecular stratification that can impact CD disease-related outcomes.
- Date of publication
- 2021
- Keyword
- DOI
- Identifier
- Resource type
- Article
- Rights statement
- In Copyright
- License
- Attribution 3.0 United States
- Journal title
- Scientific Reports
- Journal volume
- 11
- Journal issue
- 1
- Language
- English
- Version
- Publisher
- ISSN
- 2045-2322
Relations
- Parents:
- In Collection:
This work has no parents.
Items
Thumbnail | Title | Date Uploaded | Visibility | Actions |
---|---|---|---|---|
|
s41598-021-92979-2.pdf | 2021-07-07 | Public | Download |